Lizza Hendriks

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer

Kathryn C. Arbour, Laura Mezquita, Niamh M. Long et al. · Journal of Clinical Oncology · 2018 · 1.1K citations · Full text

Pharmacy, Oncology, Pharmacology +17

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Lizza Hendriks, Keith M. Kerr, Jessica Menis et al. · Annals of Oncology · 2023 · 790 citations · Full text

Medicine, Cancer Biology, Oncology +14

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 687 citations · Full text

Medicine, Oncology, Pharmacology +14

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Lizza Hendriks, Keith M. Kerr, Jessica Menis et al. · Annals of Oncology · 2023 · 580 citations · Full text

Medicine, Cancer Biology, Oncology +14

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

Anne‐Marie C. Dingemans, Martin Früh, Andrea Ardizzoni et al. · Annals of Oncology · 2021 · 574 citations · Full text

Medicine, Oncology, Surgery +14